<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WR9VRVQ" height="0" width="0" style="display:none;visibility:hidden">

Initiating Enrollment for Accelerated COVID-19 Treatment Studies in 6 Days

Initiating Enrollment for Accelerated COVID-19 Treatment Studies in 6 Days Image

In May 2020, as the FDA released new guidelines to accelerate the development of novel COVID-19 therapeutics and vaccines, our Clinical Services experts were asked to provide independent Data Safety Monitoring Board (DSMB) and Medical Monitoring resources for not just one, but two concurrent COVID-19 treatment studies scheduled to enroll Subjects in less than one week.

Find out how our dedicated project oversight paid off with two concurrent COVID-19 treatment studies initiated and ready for Subject enrollment in 6 days.

Case Study


Infographic Infographic

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Infographic

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Infographic

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...